Estados Unidos · Plataformas y datos · Finviz

Xenon to Report Q3 2026 Financial Results on November 9, 2026

Publicado por Finviz · Estados Unidos hace 9 h

About Xenon Pharmaceuticals Inc. Xenon Pharmaceuticals (Nasdaq: XENE) is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and…

Leer el artículo completo en Finviz Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finviz.com)

Xenon to Report Q3 2026 Financial Results on November 9, 2026

También te puede interesar

Empire State Realty Trust FFO of $0.20 beats by $0.02, revenue of $193.05M beats by $4.34M

AMD Reports Tuesday. Here's the Number That Will Show Whether It's Gaining on Nvidia

Traders rushing into a leveraged ETF to make a bullish bet on the Nasdaq-100 just got burned

People Inc earnings missed by $8.96, revenue fell short of estimates

Texas governor race tightens in prediction markets, but Abbott remains favored

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Xenon to Report Q3 2026 Financial Results on November 9, 2026

Compartir

También te puede interesar

Empire State Realty Trust FFO of $0.20 beats by $0.02, revenue of $193.05M beats by $4.34M

AMD Reports Tuesday. Here's the Number That Will Show Whether It's Gaining on Nvidia

Traders rushing into a leveraged ETF to make a bullish bet on the Nasdaq-100 just got burned

People Inc earnings missed by $8.96, revenue fell short of estimates

Texas governor race tightens in prediction markets, but Abbott remains favored

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030